TO-195 (hydrochlorid)
TO-195 hydrochlorid is a protease inhibitor targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . TO-195 hydrochlorid is promising for research of coronavirus disease 2019 (COVID-19) [1].
Product Specifications
CAS Number
[151328-91-5]
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(C1=CC=C(CNC(CCCC(O)=O)=O)O1)OC2=CC=C3C=C(C(N)=N)C=CC3=C2.Cl
Molecular Formula
C22H22ClN3O6
Molecular Weight
459.88
References & Citations
[1]Jonsdottir HR, et al. Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro. Biomed Pharmacother. 2022 Jun;150:113058.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6200412-01 0.1 mL
DCLK2 (Serine/Threonine-protein Kinase DCLK2, Doublecortin-like And CAM Kinase-like 2, Doublecortin-like Kinase 2, Doublecortin Domain-containing Protein 3B, CaMK-like CREB Regulatory Kinase 2, CLICK-II, CL2, DCAMKL2, DCDC3B, DCK2) (MaxLight 490)
Ask
View Details